$HUMA 8-K SEC Filings

Filed On	Filing
28 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik
12 Aug 2026	8-K: Results of Operations and Financial Condition
31 Jul 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
11 Jun 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
10 Jun 2026	8-K: Other Events
09 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
05 Jun 2026	8-K: Other Events
08 May 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
24 Apr 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
19 Mar 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
19 Mar 2026	8-K: Results of Operations and Financial Condition; Other Events
16 Dec 2025	8-K: Entry into a Material Definitive Agreement
15 Dec 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
15 Dec 2025	8-K: Termination of a Material Definitive Agreement
26 Nov 2025	8-K: Termination of a Material Definitive Agreement
12 Nov 2025	8-K: Results of Operations and Financial Condition
07 Oct 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
18 Sep 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
11 Aug 2025	8-K: Results of Operations and Financial Condition
11 Jun 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders

Comments